Identifying and Targeting Hypoxia in Head and Neck Cancer: A Brief Overview of Current Approaches
- 1 October 2007
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 69 (2), S56-S58
- https://doi.org/10.1016/j.ijrobp.2007.04.081
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: Prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1α-related markers, and hemoglobin levelsInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Do Erythropoietin Receptors on Cancer Cells Explain Unexpected Clinical Findings?Journal of Clinical Oncology, 2006
- Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomasCancer, 2006
- Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized TrialJournal of Clinical Oncology, 2006
- Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center studyRadiotherapy and Oncology, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)Journal of Clinical Oncology, 2005
- Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerNature Medicine, 2004
- Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialThe Lancet, 2003
- Heterogeneous Oxygenation of Rectal Carcinomas in Humans: A Critical Parameter for Preoperative Irradiation?Published by Springer Nature ,1984